trending Market Intelligence /marketintelligence/en/news-insights/trending/9ffcxjtbi_tyj4sl9gnn0g2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Rennova Health prices preferred stock offering

L.K. Bennett: Bankruptcy Case Study

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry


Rennova Health prices preferred stock offering

Rennova Health Inc. priced an underwritten public offering of 12,350 shares of its series H convertible preferred stock at $1,000 per share.

Each preferred share is convertible into 11,111 common shares at a conversion price of 9 cents per share.

Rennova Health expects the offering to generate $12.4 million in gross proceeds before deducting underwriting discounts and commissions and other estimated offering expenses.

About $8.3 million of the net proceeds will be used to redeem certain outstanding shares of the company's series G convertible preferred stock.

The offering is expected to close Dec. 20.

Aegis Capital Corp. is acting as the sole book-running manager for the offering.